NBCD attending EULAR 2022

June 03, 2022 The dedicated science-team from NBCD is attending EULAR these days with a poster, a poster-tour, a publication, and an oral presentation. Our CSO, Asger Bihlet, will be presenting our most recent data, suggesting a role of mast cell inhibition in the treatment of OA, based on data from a large osteoarthritis cohort on June 3rd in Auditorium 15

This year’s European Congress of Rheumatology (EULAR) marks the 75^th anniversary! The congress will be held from 1^st-4^th June in Copenhagen, Denmark, but for the first time ever, it is also possible to join the congress remote.

The aim of the EULAR congress is to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases by providing a forum of the highest standard for scientific (both clinical and basic), educational and social exchange between professionals involved in rheumatology.

The dedicated science-team from NBCD will be present at the congress, and their presentations will focus on the research in Osteoarthritis:

Oral presentation: “Antihistamine use and structural progression of knee OA: A Post-Hoc analysis of two phase III clinical trials”
Publication: “CHANGES IN PLASMA VOLUME WHEN MEASURING BIOCHEMICAL MARKERS OF JOINT TISSUE TURNOVER IN RELATION TO ACUTE PHYSICAL ACTIVITY”
Poster-tour: “The Efficacy and Safety of a Fixed-Dose Combination of Apocynin and Paeonol in Symptomatic Knee OA: A Double-blind, Randomized, Placebo-controlled Clinical Trial”
Poster: “A randomized, cross-over study to investigate the effect of weight-bearing vs non-weight-bearing exercise and cardiovascular stress on type II collagen turnover in knee osteoarthritis patients – Biomarker data from the EFEX-OA-02 study”

While in Copenhagen for the event, do not miss the chance to meet up with our team!

More information:
https://www.congress.eular.org/